J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
J2711 is a HCPCS Level II code for injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J2711
- Long descriptor
- Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- Short descriptor
- Inj neostigmin/glycopyrrolat
- Added
- January 1, 2026
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2711
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2711 is not quite right, the correct code is very often within a few positions of it.
- J2670Injection, tolazoline hcl, up to 25 mg
- J2675Injection, progesterone, per 50 mg
- J2679Injection, fluphenazine hcl, 1.25 mg
- J2680Injection, fluphenazine decanoate, up to 25 mg
- J2690Injection, procainamide hcl, up to 1 gm
- J2700Injection, oxacillin sodium, up to 250 mg
- J2704Injection, propofol, 10 mg
- J2710Injection, neostigmine methylsulfate, up to 0.5 mg
- J2720Injection, protamine sulfate, per 10 mg
- J2724Injection, protein c concentrate, intravenous, human, 10 iu
- J2725Injection, protirelin, per 250 mcg
- J2730Injection, pralidoxime chloride, up to 1 gm
- J2760Injection, phentolamine mesylate, up to 5 mg
- J2765Injection, metoclopramide hcl, up to 10 mg
- J2770Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777Injection, faricimab-svoa, 0.1 mg
Questions about J2711
What is HCPCS code J2711?
J2711 is a HCPCS Level II code for injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2711?
The CMS HCPCS file marks J2711 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J2711 paid under the physician fee schedule?
J2711 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).